A treatment protocol of Tucatinib in combination with Capecitabine and Trustuzumab in patients with previously treated unresectable locally advanced or metastatic HER2+ breast carcinoma (SGNTUC-021)
A treatment protocol of Tucatinib in combination with Capecitabine and Trustuzumab in patients with previously treated unresectable locally advanced or metastatic HER2+ breast carcinoma (SGNTUC-021)
Trial Category:
Breast
Contact(s)
Location(s)
Nebraska Cancer Specialists, Omaha, NE
